RenovoRx, Inc. Contracts & Agreements
60 Contracts & Agreements
- Business Finance (24 contracts)
- Business Operations (4)
- Human Resources (24)
- Uncategorized (8)
- Form of Placement Agent Warrant to Purchase Common Stock of RenovoRx, Inc (Filed With SEC on April 15, 2024)
- Form of Series B Warrant to Purchase Common Stock of RenovoRx, Inc (Filed With SEC on April 15, 2024)
- Form of Series A Warrant to Purchase Common Stock of RenovoRx, Inc (Filed With SEC on April 15, 2024)
- Form of Pre-Funded Common Stock Purchase Warrant of RenovoRx, Inc (Filed With SEC on April 15, 2024)
- Form of Subscription Agreement (Filed With SEC on April 15, 2024)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on April 1, 2024)
- Amended and Restated Offer Letter, dated March 8, 2024, between the Company and Leesa Gentry (Filed With SEC on March 14, 2024)
- Amended and Restated Offer Letter, dated February 9, 2024, between the Company and Ronald B. Kocak (Filed With SEC on February 9, 2024)
- RenovoRX Placement Agent Warrant (Filed With SEC on January 29, 2024)
- Placement Agent Agreement with Paulson Investment Company, LLC (Filed With SEC on January 29, 2024)
- Warrant to Purchase Common Stock of RenovoRX, Inc (Filed With SEC on January 29, 2024)
- Offering Extension (Filed With SEC on January 29, 2024)
- Subscription Agreement (Filed With SEC on January 29, 2024)
- Outside Director Compensation Policy (Filed With SEC on November 13, 2023)
- Form of Amendment to Change of Control and Severance Agreement, dated June 1, 2023 (Filed With SEC on August 16, 2023)
- Form of Securities Purchase Agreement (Filed With SEC on April 3, 2023)
- Form of Placement Agency Agreement by and between RenovoRx, Inc. and Roth Capital Partners, LLC, dated March 30, 2023 (Filed With SEC on April 3, 2023)
- Form of Common Stock Purchase Warrant (Filed With SEC on April 3, 2023)
- Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on April 3, 2023)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 31, 2023)
- Outside Director Compensation Policy (Filed With SEC on November 14, 2022)
- Change in Control and Severance Agreement by and between RenovoRx, Inc. and Angela Gill Nelms, dated August 17, 2022 (Filed With SEC on September 19, 2022)
- Offer Letter between RenovoRx, Inc. and Angela Gill Nelms (Filed With SEC on September 19, 2022)
- Consulting Agreement by and between RenovoRx, Inc. and Danforth Advisors, LLC, dated April 25, 2022 (Filed With SEC on July 19, 2022)
- Amendment to Consulting Agreement, by and between RenovoRx, Inc. and Ramtin Agah, M.D., dated January 25, 2022 (Filed With SEC on March 30, 2022)
- Amended and Restated Outside Director Compensation Policy (Filed With SEC on March 30, 2022)
- Amended and Restated 2021 Omnibus Equity Incentive Plan and Forms of Stock Option Grant Notice and Option Agreement (Filed With SEC on March 30, 2022)
- Description of Securities (Filed With SEC on March 30, 2022)
- Change in Control and Severance Agreement, by and between RenovoRx, Inc. and Ramtin Agah, effective as of November 11, 2021 (Filed With SEC on November 15, 2021)
- Key Service Provider Incentive Compensation Plan (Filed With SEC on November 15, 2021)
- Change in Control and Severance Agreement, by and between RenovoRx, Inc. and Shaun Bagai, effective as of November 11, 2021 (Filed With SEC on November 15, 2021)
- Amendment to Consulting Agreement, by and between RenovoRx, Inc. and Ramtin Agah, MD, dated November 11, 2021 (Filed With SEC on November 15, 2021)
- Consulting Agreement, by and between RenovoRx, Inc. and Ramtin Agah, MD, dated January 1, 2018 (Replaces incorrect exhibit previously filed.) (Filed With SEC on November 15, 2021)
- Confirmatory Offer Letter, by and between RenovoRx, Inc. and Shaun Bagai, dated November 11, 2021 (Filed With SEC on November 15, 2021)
- Outside Director Compensation Policy (Filed With SEC on November 15, 2021)
- 2021 Omnibus Equity Incentive Plan and Forms of Stock Option Grant Notice and Option Agreement (Filed With SEC on November 15, 2021)
- Amended and Restated Investor Rights Agreement, dated as of April 18, 2018 (Filed With SEC on November 15, 2021)
- Form of Private Common Stock Warrant (related to the 2020 Convertible Notes and 2021 Convertible Notes) (Filed With SEC on November 15, 2021)
- Form of Warrant Agent Agreement (including the terms of the Warrants) (Filed With SEC on August 12, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 12, 2021)
- Specimen Stock Certificate evidencing the Shares of Common Stock (Filed With SEC on August 5, 2021)
- Form of Underwriting Agreement (Filed With SEC on August 5, 2021)
- Form of Underwriters Warrant (Filed With SEC on August 5, 2021)
- Form of Pre-funded Warrant (Filed With SEC on August 5, 2021)
- Form of Warrant Certificate (Filed With SEC on August 5, 2021)
- Form of 2021 Equity Incentive Plan (Filed With SEC on August 5, 2021)
- Form of Indemnification Agreement (Filed With SEC on August 5, 2021)
- Client Agreement between RenovoRx, Inc. and LS Associates, Inc (Filed With SEC on August 5, 2021)
- Form of Warrant Agent Agreement (including the terms of the Warrant) (Filed With SEC on July 21, 2021)
- Master Supply Agreement dated October 28, 2019 by and between Medical Murray, Inc. and RenovoRx, Inc (Filed With SEC on July 21, 2021)
- Form of Amendment to 2020 Convertible Promissory Note (Filed With SEC on July 21, 2021)
- Form of March 2020 Convertible Promissory Note (Filed With SEC on July 21, 2021)
- Form of April 2021 Convertible Promissory Note (Filed With SEC on July 21, 2021)
- Form of Indemnification Agreement (Filed With SEC on July 21, 2021)
- Form of 2021 Equity Incentive Plan (Filed With SEC on July 21, 2021)
- Amended Consulting Agreement with Paul Manners (Filed With SEC on July 21, 2021)
- Consulting Agreement with Paul Manners (Filed With SEC on July 21, 2021)
- Amended Consulting Agreement with Ramtin Agah, MD (Filed With SEC on July 21, 2021)
- Consulting Agreement with Ramtin Agah, MD (Filed With SEC on July 21, 2021)
- 2013 Stock Incentive Plan (Filed With SEC on July 21, 2021)